DE10254872A1 - Anthranilsäureamide und deren Derivate als kosmetische und pharmazeutische Wirkstoffe - Google Patents

Anthranilsäureamide und deren Derivate als kosmetische und pharmazeutische Wirkstoffe Download PDF

Info

Publication number
DE10254872A1
DE10254872A1 DE10254872A DE10254872A DE10254872A1 DE 10254872 A1 DE10254872 A1 DE 10254872A1 DE 10254872 A DE10254872 A DE 10254872A DE 10254872 A DE10254872 A DE 10254872A DE 10254872 A1 DE10254872 A1 DE 10254872A1
Authority
DE
Germany
Prior art keywords
formula
oacyl
compound
group
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE10254872A
Other languages
German (de)
English (en)
Inventor
Gerhard Dr. Schmaus
Holger Joppe
Martina Dr. Herrmann
Christopher Dr. Sabater-Lüntzel
Tobias Vössing
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Symrise AG
Original Assignee
Symrise AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32240379&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE10254872(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Symrise AG filed Critical Symrise AG
Priority to DE10254872A priority Critical patent/DE10254872A1/de
Priority to EP03780002.6A priority patent/EP1567143B1/de
Priority to BRPI0307117A priority patent/BRPI0307117B8/pt
Priority to PCT/EP2003/012990 priority patent/WO2004047833A2/de
Priority to CNB2003801040167A priority patent/CN100548289C/zh
Priority to CN200910173877XA priority patent/CN101683310B/zh
Priority to US10/535,985 priority patent/US8203016B2/en
Priority to JP2004554400A priority patent/JP2006514931A/ja
Priority to KR1020057009267A priority patent/KR20050085127A/ko
Priority to AU2003288126A priority patent/AU2003288126A1/en
Publication of DE10254872A1 publication Critical patent/DE10254872A1/de
Priority to JP2010176413A priority patent/JP5467014B2/ja
Priority to US13/524,374 priority patent/US8409552B2/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
    • C07C233/55—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a carbon atom of an unsaturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
DE10254872A 2002-11-25 2002-11-25 Anthranilsäureamide und deren Derivate als kosmetische und pharmazeutische Wirkstoffe Withdrawn DE10254872A1 (de)

Priority Applications (12)

Application Number Priority Date Filing Date Title
DE10254872A DE10254872A1 (de) 2002-11-25 2002-11-25 Anthranilsäureamide und deren Derivate als kosmetische und pharmazeutische Wirkstoffe
AU2003288126A AU2003288126A1 (en) 2002-11-25 2003-11-20 Anthranilic acid amides and the derivatives thereof as cosmetic and pharmaceutical agents
US10/535,985 US8203016B2 (en) 2002-11-25 2003-11-20 Anthranilic acid amides and derivatives thereof as cosmetic and pharmaceutical agents
BRPI0307117A BRPI0307117B8 (pt) 2002-11-25 2003-11-20 amidas de ácido antranílico e seus derivados, bem como seus usos como compostos ativos cosméticos e farmacêuticos
PCT/EP2003/012990 WO2004047833A2 (de) 2002-11-25 2003-11-20 Anthranilsäureamide und deren derivate als kosmetische und pharmazeutische wirkstoffe
CNB2003801040167A CN100548289C (zh) 2002-11-25 2003-11-20 作为化妆品和药物活性化合物的邻氨基苯甲酰胺及其衍生物
CN200910173877XA CN101683310B (zh) 2002-11-25 2003-11-20 作为化妆品和药物活性化合物的邻氨基苯甲酰胺及其衍生物
EP03780002.6A EP1567143B1 (de) 2002-11-25 2003-11-20 Anthranilsäureamide und deren derivate als kosmetische und pharmazeutische wirkstoffe
JP2004554400A JP2006514931A (ja) 2002-11-25 2003-11-20 化粧用及び医薬用活性化合物としてのアントラニル酸アミド類及びそれらの誘導体
KR1020057009267A KR20050085127A (ko) 2002-11-25 2003-11-20 화장용 및 약제학적 활성 화합물로서의 안트라닐산 아미드및 이의 유도체
JP2010176413A JP5467014B2 (ja) 2002-11-25 2010-08-05 化粧用及び医薬用活性化合物としてのアントラニル酸アミド類及びそれらの誘導体
US13/524,374 US8409552B2 (en) 2002-11-25 2012-06-15 Anthranillic acid amides and derivatives thereof as cosmetic and pharmaceutical active compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10254872A DE10254872A1 (de) 2002-11-25 2002-11-25 Anthranilsäureamide und deren Derivate als kosmetische und pharmazeutische Wirkstoffe

Publications (1)

Publication Number Publication Date
DE10254872A1 true DE10254872A1 (de) 2004-06-03

Family

ID=32240379

Family Applications (1)

Application Number Title Priority Date Filing Date
DE10254872A Withdrawn DE10254872A1 (de) 2002-11-25 2002-11-25 Anthranilsäureamide und deren Derivate als kosmetische und pharmazeutische Wirkstoffe

Country Status (9)

Country Link
US (2) US8203016B2 (https=)
EP (1) EP1567143B1 (https=)
JP (2) JP2006514931A (https=)
KR (1) KR20050085127A (https=)
CN (2) CN100548289C (https=)
AU (1) AU2003288126A1 (https=)
BR (1) BRPI0307117B8 (https=)
DE (1) DE10254872A1 (https=)
WO (1) WO2004047833A2 (https=)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074831B2 (en) 2004-02-06 2006-07-11 Active Biotech Ab Compounds, methods for their preparation and use thereof
WO2015180740A1 (en) * 2012-12-20 2015-12-03 Kao Germany Gmbh Oxidative dyeing composition
WO2019179639A1 (en) 2018-03-23 2019-09-26 Symrise Ag Skin condition improving agents
KR20200095266A (ko) * 2019-01-31 2020-08-10 경북대학교 산학협력단 아베난트라미드 c를 유효성분으로 포함하는 알레르기 질환 예방, 치료 또는 개선용 조성물

Families Citing this family (166)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060100274A1 (en) * 2004-11-05 2006-05-11 Trustees Of Tufts College Therapeutic avenanthramide compounds
ITMI20050674A1 (it) * 2005-04-15 2006-10-16 Univ Degli Studi Milano Uso di derivati ammidici come agenti modificatori del gusto composizioni aromatizzanti e prodotti che li contengono
WO2006134013A1 (en) * 2005-06-14 2006-12-21 Symrise Gmbh & Co. Kg Mixtures comprising anthranilic acid amides and cooling agents as cosmetic and pharmaceutical compositions for alleviating itching
US20070059268A1 (en) * 2005-09-09 2007-03-15 Laura Magee Compositions, methods and kits for treating allergic dermatitis of skin
US20070059679A1 (en) * 2005-09-09 2007-03-15 Michelle Garay Method for demonstrating efficacy of a topically applied active ingredient
US20070059390A1 (en) * 2005-09-09 2007-03-15 Laura Magee Compositions for inhibiting or reducing inflammation of skin
US20070185038A1 (en) * 2005-09-30 2007-08-09 The Procter & Gamble Company Regulation of mammalian keratinous tissue using skin care actives
EP1959915B1 (en) 2005-11-30 2015-05-13 Symrise AG Mixtures comprising anthranilic acid amides and antidandruff agents as cosmetic and pharmaceutical compositions for alleviating itching
EP1886662B1 (de) 2006-06-14 2014-04-09 Symrise AG Antimikrobiell wirksame Verbindungen zur Behandlung von Mundgeruch
ES2462925T3 (es) * 2006-06-14 2014-05-26 Symrise Ag Compuestos con efecto antimicrobiano para el tratamiento de fetidez oral
MX352516B (es) 2006-07-05 2017-04-06 Fibrotech Therapeutics Pty Ltd Compuestos terapeuticos.
JP5349332B2 (ja) * 2007-02-06 2013-11-20 チェルシー・セラピューティクス，インコーポレイテッド 新規化合物、その調製方法、およびその使用
EP2455134B1 (en) 2007-04-19 2016-05-11 Mary Kay, Inc. Magnolia extract containing compositions
WO2008131481A1 (en) * 2007-04-26 2008-11-06 Fibrotech Therapeutics Pty Ltd Treatment of mesangioproliferative diseases
US20100267662A1 (en) * 2007-11-08 2010-10-21 Ceapro, Inc. Avenanthramide-containing compositions
CA2709937C (en) * 2007-12-21 2016-03-22 Fibrotech Therapeutics Pty Ltd Halogenated analogues of anti-fibrotic agents
JP4979655B2 (ja) * 2008-08-07 2012-07-18 キヤノン株式会社 画像符号化装置及びその制御方法
US9533479B2 (en) 2008-09-18 2017-01-03 Medline Industries, Inc. Absorbent articles having antimicrobial properties and methods of manufacturing the same
EP2168570B1 (en) 2008-09-30 2013-12-25 Symrise AG Extracts of isochrysis sp.
EP2193785B1 (en) 2008-12-05 2018-07-18 Symrise AG Extracts of Tetraselmis sp. for cosmetic and therapeutic purposes
US20100160351A1 (en) * 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2010071865A1 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
EP2416766B1 (en) 2009-04-09 2014-04-09 Symrise AG Compositions comprising trans-tert-butyl cyclohexanol as skin irritation-reducing agent
BRPI0924661B1 (pt) 2009-04-28 2018-12-11 Symrise Ag Ômega-ciclo-hexilalcan-1-óis, seus métodos de produção, suas composições, suas formulações cosméticas, uso dos mesmos como ativos microbianos e método parareduzir a taxa de crescimento de corynebacterium xerosis e/ou staphylococcus epidermidis e/ou brevibacterium epidermidis
FR2945213B1 (fr) * 2009-05-07 2015-10-16 Rocher Yves Biolog Vegetale Compositions cosmetiques et dermatologiques et dermatologiques a base d'extrait de silene.
US9717818B2 (en) 2009-05-08 2017-08-01 Medline Industries, Inc. Absorbent articles having antimicrobial properties and methods of manufacturing the same
EP2295031B1 (de) 2009-08-05 2018-01-10 Symrise AG Verwendung von Pterocarpanen als Anti-Cellulite-Wirkstoffe
EP2174645B1 (de) 2009-10-19 2015-07-29 Symrise AG Riechstoffhaltige Zusammensetzungen umfassend Cetylnonanoat und/oder Stearylnonanoat
ATE537244T1 (de) * 2009-10-19 2011-12-15 Symrise Ag Riechstoffmischungen enthaltend isolongifolanol und moschus
CN102574843B (zh) 2009-10-22 2015-06-17 法博太科制药有限公司 抗纤维化剂的稠环类似物
EP2158896A3 (de) 2009-11-02 2010-09-29 Symrise GmbH & Co. KG Riechstoffhaltige Zusammensetzungen umfassend Neopentylglycoldiisononanoat
EP2359702B1 (en) 2010-01-22 2014-06-04 Symrise AG Solubilization agent for solubilizing polyphenols, flavonoids and/or diterpenoid glucosides
JP5714694B2 (ja) 2010-04-08 2015-05-07 シムライズ アーゲー ジヒドロデヒドロジイソオイゲノールの使用およびジヒドロデヒドロジイソオイゲノールを含む製剤
EP2389922A1 (en) 2010-05-25 2011-11-30 Symrise AG Cyclohexyl carbamate compounds as anti-ageing actives
EP2286908A3 (de) 2010-11-19 2011-06-01 Symrise AG Lösungsvermittler für kosmetische Zubereitungen
EP2457554A1 (de) 2010-11-24 2012-05-30 Symrise AG Menthol enthaltende Mischung
EP2356977B1 (de) 2011-02-02 2017-12-27 Symrise AG Zubereitungen mit Holzextrakten von Gleditschien
EP2524959B1 (de) 2011-05-17 2014-01-22 Symrise AG Riech- und/oder Aromastoffkompositionen enthaltend Dioxolane
DE102011082464A1 (de) 2011-09-09 2011-12-01 Symrise Ag Riechstoffmischungen enthaltend bestimmte Isolongifolenylmethylether
WO2013041130A1 (de) 2011-09-20 2013-03-28 Symrise Ag Acetale und ketale als riech- und aromastoffe
EP2474301B1 (de) 2011-12-14 2014-04-16 Symrise AG Riechstoffmischungen enthaltend Cyclopent-2-Enyl-Essigsäureethylester
WO2013112040A1 (en) 2012-01-27 2013-08-01 Biotropics Malaysia Berhad Use of certain trioxygenated benzene derivatives in body fat management
US20150050371A1 (en) 2012-03-09 2015-02-19 Biotropics Malaysia Berhad Extract Formulations of Rhodamnia Cinerea And Uses Thereof
EP3398656B1 (en) 2012-06-15 2023-01-11 Symrise AG Compositions comprising hyaluronan biosynthesis promoting agents
EP2695597B1 (en) 2012-08-07 2019-07-24 Symrise AG Cosmetic compositions
US20160008297A1 (en) 2012-08-23 2016-01-14 B.R.A.I.N. Biotechnology Research And Information Network Ag Compounds for preventing, reducing and/or alleviating itchy skin condition(s)
EP2745878B1 (en) 2012-12-19 2023-01-25 Symrise AG Cosmetic compositions
EP2764860A1 (en) 2013-02-06 2014-08-13 Basf Sa Cupuassu fatty acid amidoamines and their derivatives
ES2701758T3 (es) 2013-02-27 2019-02-25 Symrise Ag Extracto de jengibre para la protección de citoblastos
EP2774604B1 (en) 2013-03-08 2017-08-30 Symrise AG Cosmetic compositions
EP2774481B1 (en) 2013-03-08 2018-06-13 Symrise AG Antimicrobial compositions
EP2783578A1 (en) 2013-03-26 2014-10-01 Symrise AG Catechin reaction products
EP2789369B1 (en) 2013-04-14 2018-06-06 Symrise AG A composition for lightening skin and hair
US10188754B2 (en) 2013-05-16 2019-01-29 The Johns Hopkins University Compositions and methods for chemical exchange saturation transfer (CEST) based magnetic resonance imaging (MRI)
EP2807925A1 (en) 2013-05-26 2014-12-03 Symrise AG Antimicrobial compositions
EP2810934A1 (en) 2013-06-09 2014-12-10 Symrise AG New succinate derivatives
EP2842607B1 (en) 2013-09-02 2018-05-30 Symrise AG A skin and/or hair whitening mixture
CN104418764B (zh) * 2013-09-11 2017-02-01 上海伊明化学科技有限公司 一种二氢燕麦酰基邻氨基苯甲酸d合成方法
CN112294853A (zh) 2013-09-22 2021-02-02 西姆莱斯股份公司 海马齿苋提取物及其应用
EP2853254B1 (en) 2013-09-26 2017-11-08 Symrise AG A composition for lightening skin and/or hair
EP2859883B1 (en) 2013-10-13 2019-05-15 Symrise AG Active mixtures comprising acylated oligopeptides and troxerutin
EP2862852B1 (en) 2013-10-18 2018-07-04 Symrise AG Urea derivatives for the protection of stem cells
WO2015062629A1 (en) 2013-10-29 2015-05-07 Cutech Srl Use of mono ornithine ketoglutarate (mokg)
WO2015138926A1 (en) 2014-03-14 2015-09-17 Gojo Industries, Inc. Hand sanitizers with improved aesthetics and skin-conditioning to encourage compliance with hand hygiene guidelines
EP2962678A1 (en) 2014-06-30 2016-01-06 Symrise AG Flavour and fragrance compositions comprising acetophenone derivatives
EP2979682B1 (en) 2014-07-30 2018-09-05 Symrise AG A fragrance composition
EP3023090B1 (en) 2014-11-21 2019-08-07 Symrise AG Compositions
EP3045161B1 (en) 2015-01-18 2026-03-25 Symrise AG Use of active mixtures of 1,2-hexanediol and 1,2-octanediol in cosmetic, pharmaceutical or dermatological emulsions
PL3081207T3 (pl) 2015-04-16 2023-03-20 Symrise Ag Zastosowanie kompozycji liposomowej
US10391071B2 (en) 2015-04-28 2019-08-27 Cutech Srl Compositions comprising valerian extracts
EP3097905B1 (en) 2015-05-28 2020-11-04 Symrise AG Cosmetic compositions
EP3108941B1 (en) 2015-06-23 2018-05-09 Symrise AG Compositions comprising polyalkylene glycol derivatives
CN105078821A (zh) * 2015-08-14 2015-11-25 台山美环健芦荟制品有限公司 一种含芦荟鲜汁的抗刺激抗过敏产品及其制备方法
CN107922882A (zh) 2015-09-08 2018-04-17 西姆莱斯股份公司 香料混合物
EP3367994B1 (en) 2015-10-28 2021-05-12 Symrise AG Method for inhibiting or masking fishy odours
US12053537B2 (en) 2015-11-15 2024-08-06 Symrise Ag Reduction of stinging sensation on skin
WO2017097434A1 (en) 2015-12-06 2017-06-15 Symrise Ag A fragrance composition
US12226501B2 (en) 2015-12-10 2025-02-18 Symrise Ag Composition with stabilized taste and odor
EP4477092A3 (en) 2015-12-16 2025-02-26 Symrise AG Use of 4-hydroxyacetophenone to stabilize taste and odor
ES2733201T3 (es) 2015-12-21 2019-11-28 Thiocyn Gmbh Composición cosmética que comprende una combinación de sustancias activas
EP3090727B8 (en) 2016-01-13 2019-06-19 Thiocyn GmbH Hair growth composition
US10876067B2 (en) 2016-02-15 2020-12-29 Symrise Ag Fragrant mixtures containing esters and ketones
US11918679B2 (en) 2016-03-30 2024-03-05 Symrise Ag Active mixure
CN105902423A (zh) * 2016-04-15 2016-08-31 欧标（广州）化妆品有限公司 一种使皮肤色泽均匀及提亮肤色的美白面膜组合物
US11400035B2 (en) 2016-08-20 2022-08-02 Symrise Ag Preservative mixture
CN109642184A (zh) 2016-09-01 2019-04-16 西姆莱斯有限公司 包括塑料容器和物质组合物的产品
MX2018014358A (es) 2016-10-11 2019-03-14 Symrise Ag Composiciones antimicrobianas.
WO2018099580A1 (en) 2016-12-01 2018-06-07 Symrise Ag Mixtures comprising phenyl alkanol and linear alcohol
US11123272B2 (en) 2016-12-02 2021-09-21 Symrise Ag Cosmetic blends
CN106631865A (zh) * 2016-12-19 2017-05-10 南京华狮新材料有限公司 一种燕麦生物碱及其衍生物的制备方法
JP7185631B2 (ja) 2017-02-03 2022-12-07 サータ セラピューティクス プロプライエタリー リミテッド 抗線維化化合物
CN110520513B (zh) 2017-03-21 2024-01-09 西姆莱斯有限公司 包含三环[5.2.1.0]-癸烷-8-乙基醚的芳香剂混合物
WO2018171871A1 (de) 2017-03-21 2018-09-27 Symrise Ag 2,3,6-trimethylcyclohexanol als riech- und/oder aromastoff
CN110494539B (zh) 2017-03-21 2021-04-02 西姆莱斯有限公司 5-双环[2.2.1]庚-2-烯基-乙酸酯作为芳香剂和/或调味剂
WO2018192652A1 (de) 2017-04-19 2018-10-25 Symrise Ag 1,1-dimeth/ethoxynon-3-in als riechstoff
JP6928671B2 (ja) 2017-04-21 2021-09-01 シムライズ アーゲー 芳香剤としての４−エチル−オクテン−２／３−ニトリル
WO2018196988A1 (de) 2017-04-28 2018-11-01 Symrise Ag Ethyl-2-acetyl-2,4-dimethyl-pent-4-enoat als riechstoff
IT201700090929A1 (it) 2017-08-07 2019-02-07 Cutech S R L Usi cosmetici e medici di estratti del fungo Coprinus comatus per la regolazione dell’unità pilo sebacea.
DE202017007679U1 (de) 2017-08-09 2024-03-15 Symrise Ag 1,2-Alkandiole
EP3664772B1 (en) 2017-08-09 2024-03-20 Symrise AG 1,2-alkanediols and a process for their production
CN107625680B (zh) * 2017-09-26 2020-07-10 杭州梵琳科技有限公司 舒敏水剂及其制备方法
WO2019072375A1 (en) 2017-10-10 2019-04-18 Symrise Ag COMPOSITIONS CONTAINING BENZOIC ACID OR FUROIC ACID DERIVATIVES AND USE OF THE DERIVATIVES FOR EMULSION AND FOAM STABILITY
CN107868019A (zh) * 2017-11-09 2018-04-03 福州美乐莲生物科技有限公司 二氢燕麦生物碱类化合物、衍生物及其制备方法和应用
WO2019114969A1 (de) 2017-12-14 2019-06-20 Symrise Ag Riechstoffmischungen enthaltend 8,8-dimethyl-6,10-dioxaspiro[4,5]decan
WO2019166088A1 (en) 2018-02-28 2019-09-06 Symrise Ag Tetraselmis extract
WO2019166089A1 (en) 2018-02-28 2019-09-06 Symrise Ag Dermatological product
CN111936120A (zh) 2018-03-08 2020-11-13 西姆莱斯股份公司 用于处理人类皮肤和/或毛发的包含蛋白质提取物的混合物
WO2018154145A2 (en) 2018-03-29 2018-08-30 Symrise Ag Compounds for skin improvement / treatment
CN112469685B (zh) 2018-07-23 2024-01-02 西姆莱斯股份公司 具有玫瑰气味的新型香味剂
CA3113469A1 (en) 2018-08-27 2020-03-05 Symrise Ag Antimicrobial mixtures comprising at least one hydroxyphenone derivative
US12403076B2 (en) 2018-09-20 2025-09-02 Symrise Ag Compositions comprising odorless 1,2-pentanediol
CA3131978A1 (en) 2019-03-12 2020-09-17 Symrise Ag An antimicrobial mixture
CN113840540B (zh) 2019-05-17 2024-04-30 西姆莱斯股份公司 香料或调味剂混合物
WO2021008696A1 (de) 2019-07-16 2021-01-21 Symrise Ag Riechstoffmischung enthaltend 1,3-propandiol
CN110981925B (zh) * 2019-11-18 2021-05-25 福州百草堂医药科技有限公司 二氢燕麦生物碱d葡萄糖苷或其盐类化合物及其在化妆品中的应用
EP4114348A1 (en) 2020-03-06 2023-01-11 Symrise AG Composition comprising an aventhramide or an analogue thereof with improved stability
KR20250141837A (ko) 2020-03-06 2025-09-29 시므라이즈 아게 아베난쓰라미드 l의 화장품 또는 약제학적 용도
WO2021175452A1 (en) 2020-03-06 2021-09-10 Symrise Ag Composition comprising an avenanthramide or an analogue thereof with improved skin penetration
ES3001283T3 (en) 2020-03-06 2025-03-05 Symrise Ag Avenanthramide compositions with improved solubility comprising 4-hydroxyphenone
BR112022017293A2 (pt) * 2020-03-06 2022-10-11 Symrise Ag Composição ou extrato de aveia compreendendo avenantramida e ss-glucano
WO2021204380A1 (en) 2020-04-08 2021-10-14 Symrise Ag Esters as fragrance compounds
CN111302969A (zh) * 2020-04-08 2020-06-19 福建莲珂科技有限公司 邻氨基苯甲酸衍生物及其用途
EP3944853A1 (en) 2020-07-31 2022-02-02 Basf Se Liquid l-menthol composition
US11369552B1 (en) 2020-09-11 2022-06-28 Elena Yurievna Komarova Aqueous nail polish remover
WO2022111793A1 (en) 2020-11-24 2022-06-02 Symrise Ag Medicament for accelerated wound healing
WO2022111829A1 (en) 2020-11-30 2022-06-02 Symrise Ag Essential oils of citrus fruits for use as medicament for induced, increased and/or accelerated autophagy in human keratinocytes
WO2022122122A1 (en) 2020-12-08 2022-06-16 Symrise Ag Medicament for fighting inflammatory conditions of human skin (i)
WO2022122135A1 (en) 2020-12-09 2022-06-16 Symrise Ag Compositions comprising (bio)-alkanediols with antimicrobials for product protection
WO2022122137A1 (en) 2020-12-09 2022-06-16 Symrise Ag Compositions comprising antimicrobials and (bio)-alkanediols for skin protection
WO2022122140A1 (en) 2020-12-09 2022-06-16 Symrise Ag Compositions comprising one or more (bio)-alkanediols with active ingredients
WO2022122131A1 (en) 2020-12-09 2022-06-16 Symrise Ag Compositions comprising lipophilic compounds and one or more (bio)-alkanediols
WO2022122133A1 (en) 2020-12-09 2022-06-16 Symrise Ag Compositions comprising uv-filters and one or more (bio)-alkanediols
WO2022122136A1 (en) 2020-12-09 2022-06-16 Symrise Ag Compositions comprising one or more (bio)-alkanediols with antioxidants
WO2022122138A1 (en) 2020-12-09 2022-06-16 Symrise Ag Multifunctional compound mixtures comprising multiple (bio)-alkanediols
US20240050337A1 (en) 2020-12-09 2024-02-15 Symrise Ag A mixture comprising 1,2-alkanediols
WO2022122134A1 (en) 2020-12-09 2022-06-16 Symrise Ag Compositions with (bio)-alkanediols and cooling agents
WO2022122132A1 (en) 2020-12-09 2022-06-16 Symrise Ag Compositions comprising natural polymers and one or more (bio)-alkanediols
WO2022122167A1 (en) 2020-12-11 2022-06-16 Symrise Ag Medicament for preventing or treating pathologic conditions of human skin (i)
CA3201865A1 (en) 2020-12-14 2022-06-23 Symrise Ag Extracts of isochrysis species / tisochrysis species
WO2022128164A1 (en) 2020-12-14 2022-06-23 Symrise Ag Extracts of isochrysis species / tisochrysis species
WO2022128050A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for fighting inflammation and pain
EP4259088A1 (en) 2020-12-14 2023-10-18 Symrise AG Cosmetic and/or pharmaceutical compositions containing cannabinoids
WO2022128057A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for prevention and treatment of collagen degradation in human connecting tissue
WO2022128054A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for fighting inflammatory conditions of human skin (iv)
WO2022128052A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for fighting inflammatory conditions of human skin
WO2022128048A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for preventing or treating pathologic conditions of human skin
WO2022128051A1 (en) 2020-12-14 2022-06-23 Symrise Ag Medicament for fighting inflammatory conditions of human skin (ii)
KR20230145150A (ko) 2021-02-12 2023-10-17 시므라이즈 아게 과색소 침착의 예방 및 치료를 위한 약제 (medicament)
KR20240038040A (ko) 2021-07-23 2024-03-22 시므라이즈 아게 디카페오일퀸산 및 디카페오일퀸산과 토코페롤의 상승작용
US12329704B2 (en) 2021-08-23 2025-06-17 Medline Industries, Lp Absorbent repositioning pad and method
CN117940541A (zh) 2021-09-13 2024-04-26 西姆莱斯有限公司 环丙烷化香料化合物
CN119604267A (zh) 2022-08-05 2025-03-11 西姆莱斯股份公司 具有改进的spf和uva光防护的组合物
CN119604270A (zh) 2022-08-05 2025-03-11 西姆莱斯股份公司 包含抗微生物促进剂的组合物
WO2024027930A1 (en) 2022-08-05 2024-02-08 Symrise Ag Compositions comprising an antimicrobial boosting agent
CN119584951A (zh) 2022-08-05 2025-03-07 西姆莱斯股份公司 包含uv滤光剂稳定剂的组合物
EP4565193A1 (en) 2022-08-05 2025-06-11 Symrise AG Composition with improved water resistance
WO2024027929A1 (en) 2022-08-05 2024-02-08 Symrise Ag Composition with improved water resistance
WO2024028513A1 (en) 2022-08-05 2024-02-08 Symrise Ag Odor and colorant stabilized compositions
WO2024027931A1 (en) 2022-08-05 2024-02-08 Symrise Ag Odor and colorant stabilized compositions
WO2024256011A1 (en) 2023-06-15 2024-12-19 Symrise Ag Stabilizer or stabilizer composition for stabilizing dihydroavenanthramide d
CN121712481A (zh) 2023-08-04 2026-03-20 西姆莱斯股份公司 类菌孢素氨基酸类似物化合物及其用途
WO2025176314A1 (en) 2024-02-23 2025-08-28 Symrise Ag Liquid uv filter concentrate
WO2025176315A1 (en) 2024-02-23 2025-08-28 Symrise Ag Liquid uv filter composition containing diols
WO2025195569A1 (en) 2024-03-18 2025-09-25 Symrise Ag Dihydroavenanthramide d for reducing fragrance degradation
WO2025195570A1 (en) 2024-03-18 2025-09-25 Symrise Ag Dihydroavenanthramide d powder
CN119978040B (zh) * 2025-04-17 2025-07-18 上海际研生物医药开发有限公司 Hmgb1抑制剂、从火绒草提取物中靶向制备hmgb1抑制剂的方法及应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5126839B1 (https=) 1970-01-16 1976-08-09
US4070484A (en) * 1973-01-18 1978-01-24 Kissei Pharmaceutical Co., Ltd. Antiallergic composition containing aromatic carboxylic amide derivatives and method of using the same
JPS5640710B2 (https=) 1973-01-18 1981-09-22
JPS5736905B2 (https=) * 1974-04-17 1982-08-06
JPS5126839A (ja) * 1974-08-21 1976-03-05 Dainippon Pharmaceutical Co Benzuaniridojudotaino seizoho
US4347188A (en) * 1977-01-06 1982-08-31 Sumitomo Chemical Company, Limited N-Benzoylanthranilate derivatives
US4337270A (en) * 1980-05-21 1982-06-29 Hisamitsu Pharmaceutical Co., Inc. Novel anthranilic acid derivatives
JPS5736905A (ja) 1980-08-12 1982-02-27 Iseki Agricult Mach Naeishokuki
JPS5817186B2 (ja) 1981-01-23 1983-04-05 キツセイ薬品工業株式会社 新規芳香族カルボン酸誘導体の製造方法
JPS5838444A (ja) 1981-08-29 1983-03-05 Shimadzu Corp クロマトグラフ質量分析計
US4587356A (en) 1981-09-01 1986-05-06 Kissei Pharmaceutical Co., Ltd. Process for the production of nuclear substituted cinnamoylanthranilic acid derivatives
JPS5838244A (ja) 1981-09-01 1983-03-05 Kissei Pharmaceut Co Ltd 核置換シンナモイルアントラニル酸塩およびその製造方法
JPS60116657A (ja) * 1983-11-30 1985-06-24 Ono Pharmaceut Co Ltd アニリン誘導体
JPS60146856A (ja) * 1983-12-30 1985-08-02 Kissei Pharmaceut Co Ltd α−ハロ芳香族アミドカルボン酸誘導体及びこの化合物より成る抗アレルギ−剤
JPH0733357B2 (ja) 1986-09-30 1995-04-12 日本レダリ−株式会社 ケイ皮酸誘導体
JPH07116029B2 (ja) * 1989-04-04 1995-12-13 キッセイ薬品工業株式会社 トラニラスト水溶液製剤
CA2017287A1 (en) * 1989-05-23 1990-11-23 Shunji Naruto Substituted phenol derivatives and their use
JPH08143525A (ja) * 1994-11-21 1996-06-04 Banyu Pharmaceut Co Ltd ヒドロキシ安息香酸アミド誘導体を有効成分とする骨疾患の予防・治療剤
FR2737408B1 (fr) * 1995-07-31 1997-09-05 Oreal Utilisation d'un antagoniste de bradykinine dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
JP3621483B2 (ja) * 1995-12-01 2005-02-16 花王株式会社 ヒスタミン遊離抑制剤
AU724646B2 (en) * 1996-03-15 2000-09-28 Eli Lilly And Company Method of treating common cold or allergic rhinitis
CA2368218C (en) * 1999-05-06 2011-08-23 Mark J. Redmond Oat extracts: refining, compositions and methods of use
JP4687837B2 (ja) 1999-09-29 2011-05-25 ライオン株式会社 眼科用組成物
JP4488560B2 (ja) * 1999-10-26 2010-06-23 一丸ファルコス株式会社 保湿性植物抽出物を含有する化粧料組成物
ES2462925T3 (es) * 2006-06-14 2014-05-26 Symrise Ag Compuestos con efecto antimicrobiano para el tratamiento de fetidez oral

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074831B2 (en) 2004-02-06 2006-07-11 Active Biotech Ab Compounds, methods for their preparation and use thereof
WO2015180740A1 (en) * 2012-12-20 2015-12-03 Kao Germany Gmbh Oxidative dyeing composition
US9770397B2 (en) 2012-12-20 2017-09-26 Kao Germany Gmbh Oxidative dyeing composition
WO2019179639A1 (en) 2018-03-23 2019-09-26 Symrise Ag Skin condition improving agents
WO2019180266A1 (en) 2018-03-23 2019-09-26 Symrise Ag Skin condition improving agents
KR20200095266A (ko) * 2019-01-31 2020-08-10 경북대학교 산학협력단 아베난트라미드 c를 유효성분으로 포함하는 알레르기 질환 예방, 치료 또는 개선용 조성물
KR102192624B1 (ko) * 2019-01-31 2020-12-17 경북대학교 산학협력단 아베난트라미드 c를 유효성분으로 포함하는 알레르기 질환 예방, 치료 또는 개선용 조성물

Also Published As

Publication number Publication date
US20120315233A1 (en) 2012-12-13
WO2004047833A2 (de) 2004-06-10
JP2006514931A (ja) 2006-05-18
CN100548289C (zh) 2009-10-14
US8409552B2 (en) 2013-04-02
BRPI0307117B1 (pt) 2017-07-18
AU2003288126A1 (en) 2004-06-18
CN101683310A (zh) 2010-03-31
EP1567143A2 (de) 2005-08-31
BR0307117A (pt) 2004-12-28
CN101683310B (zh) 2012-12-12
KR20050085127A (ko) 2005-08-29
WO2004047833A3 (de) 2005-01-13
JP5467014B2 (ja) 2014-04-09
JP2010248268A (ja) 2010-11-04
US20060089413A1 (en) 2006-04-27
BRPI0307117B8 (pt) 2021-05-25
CN1713904A (zh) 2005-12-28
US8203016B2 (en) 2012-06-19
EP1567143B1 (de) 2013-08-14

Similar Documents

Publication Publication Date Title
EP1567143B1 (de) Anthranilsäureamide und deren derivate als kosmetische und pharmazeutische wirkstoffe
EP1633206B1 (de) Verwendung von diphenylmethan-derivaten als tyrosinase-inhibitoren
EP1478231B1 (de) Synergistische mischungen von 1,2-alkandiolen
EP1915982A1 (de) Verwendung von 1,2-Decandiol zur Sebumreduktion bzw. zur Unterstützung des Eindringens von Wirkstoffen in Hautbereiche, sowie kosmetische und/oder dermatologische Zubereitungen umfassend 1,2-Decandiol
DE10324567A1 (de) Verwendung von Diphenylmethan-Derivaten als antimikrobielle Wirkstoffe
DE102008009929A1 (de) 3-(4-Hydroxy-3-methoxyphenyl)-1(4-hydroxphenyl)-1-propanon und deren Verwendung in kosmetischen und pharmazeutischen Zubereitungen
EP1535604B1 (de) Wirkstoffkombination aus Kreatin und Kreatinin, Phenoxyethanol und Glycerin
WO2002069925A2 (de) VERWENDUNG VON WIRKSTOFFKOMBINATIONEN AUS α-LIPONSÄURE UND DERMATOLOGISCH VERTRÄGLICHEN SUBSTANZEN, DIE LICHTABSORPTION IM UV-A-BEREICH UND/ODER UV-B-BEREICH ZEIGEN, ZUR HERSTELLUNG VON KOSMETISCHEN ODER DERMATOLOGISCHEN ZUBEREITUNGEN
DE20221386U1 (de) Synergistische Mischungen von 1,2-Alkandiolen
EP1535606B1 (de) Wirkstoffkombinationen Kreatin und/oder Kreatinin und einer wirksamen Menge an Retinylpalmitat und Zubereitungen, solche Wirkstoffkombinationen enthaltend
DE10111048A1 (de) Verwendung von alpha-Liponsäure zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Regeneration beanspruchter Haut, insbesondere der gealterten Haut
DE20318416U1 (de) Wirkstoffkombinationen Kreatin und/oder Kreatinderivaten und/oder Kreatinin und/oder Kreatininderivaten und einer wirksamen Menge an Retinoiden, insbesondere Retinol bzw. Retinylpalmitat und Zubereitungen, solche Wirkstoffkombinationen enthaltend
DE10121090A1 (de) Wirkstoffkombinationen aus Tetrahydrocurcuminoiden und Sericosid und/oder Pflanzenextrakten
EP1172103A2 (de) Wirkstoffkombination aus 3-lodo-2-propinyl-butylcarbamat und einem oder mehreren 4-Hydroxybenzoesäureestern und Zubereitungen, solche Wirkstoffkombinationen enthaltend
DE10207274A1 (de) Wirkstoffkombinationen aus Tetrahydrocurcuminoiden und alpha-Liponsäure
DE20318413U1 (de) Wirkstoffkombinationen aus Kreatin und/oder Kreatinin, Phenoxyethanol und gewünschtenfalls Glycerin
DE10121089A1 (de) Wirkstoffkombinationen aus Tetrahydrocurcuminoiden und Substanzen, die verhindern, dass die NO-Synthase des warmblütigen Organismus seine Wirkung entfaltet
WO2003101407A1 (de) Verwendung von jelängerjelieber blütenextraktzur herstellung kosmeticher oder dermatologischer zubereitungen zur prophylaxe und behandlung von entzündlichen hautzuständen und/oder zum hautschutz bei empfindlich determinierter haut
EP1172086A1 (de) Wirkstoffkombinationen aus 3-lodo-2-propinyl-butylcarbamat und Phenoxyethanol und Zubereitungen, solche Wirkstoffkombinationen enthaltend
EP1172102A2 (de) Wirkstoffkombination aus 3-Iodo-2-propinyl-carbamat, einem oder mehreren 4-Hydroxybenzoesäureester und Phenoxyethanol und Zubereitungen, solche Wirkstoffkombinationen enthaltend
DE20022972U1 (de) Wirkstoffkombinationen aus 3-Iodo-2-propinyl-butylcarbamat und Phenoxyethanol und Zubereitungen, solche Wirkstoffkombinationen enthaltend
DE20022971U1 (de) Wirkstoffkombinationen aus 3-Iodo-2-propinyl-butylcarbamat und einem oder mehreren 4-Hydroxybenzoesäureestern und Zubereitungen, solche Wirkstoffkombinationen enthaltend
DE102006012107A1 (de) Verwendung von Estern der Angelicasäure als antiphlogistischen Wirkstoff, sowie antiphlogistische Zubereitungen
DE20022973U1 (de) Wirkstoffkombinationen aus 3-Iodo-2-propinyl-butylcarbamat, einem oder mehreren 4-Hydroxybenzoesäureester und Phenoxyethanol und Zubereitungen, solche Wirkstoffkombinationen enthaltend

Legal Events

Date Code Title Description
8141 Disposal/no request for examination